b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30315626</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>06</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>06</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1864-0648</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>12</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>02</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of biophotonics</Title>\n                <ISOAbbreviation>J Biophotonics</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Fluorescence intensity modulation of CdSe/ZnS quantum dots assesses reactive oxygen species during chemotherapy and radiotherapy for cancer cells.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>e201800172</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jbio.201800172</ELocationID>\n            <Abstract>\n                <AbstractText>Quantum dots (QDs) are semiconductor nanoparticles ranging in size from 2 to 10 nm. QDs are increasingly being developed for biomedical imaging, targeted drug delivery and green energy technology. These have led to much research on QD interactions with various physical, chemical and biological systems. For biological systems, research has focused on the biocompatibility/cytotoxicity of QDs in the context of imaging/therapy. However, there is a paucity of work on how biological systems and bioactive molecules might be used to alter the optoelectronic properties of QDs. Here, it is shown that these properties can be altered by reactive oxygen species (ROS) from chemotherapeutic media and biological cells following controlled changes in cellular activities. Using CdSe/ZnS core-shell QDs, spectroscopic analysis of optically excited QDs with HL60, K562 and T98G cancer cell lines is performed. Our results show statistically significant (P\xe2\x80\x89&lt;\xe2\x80\x890.0001) modulation of the fluorescence emission spectra of the QDs due to the ROS produced by common chemotherapeutic drugs, daunorubicin and doxorubicin and by cells following chemotherapy/radiotherapy. This optical modulation, in addition to assessing ROS generation, will possibly enhance applications of QDs in simultaneous diagnostic imaging and nanoparticle-mediated drug delivery as well as simultaneous ROS assessment and radiosensitization for improved outcomes in cancer treatments. Reactive molecular species produced by biological cells and chemotherapeutic drugs can create electric fields that alter the photophysical properties of QDs, and this can be used for concurrent monitoring of cellular activities, while inducing changes in those cellular activities.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2018 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Bong H</ForeName>\n                    <Initials>BH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Physics, Creighton University, Omaha, Nebraska.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Suresh</LastName>\n                    <ForeName>Sindhuja</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Computer Science, Creighton University, Omaha, Nebraska.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ekpenyong</LastName>\n                    <ForeName>Andrew</ForeName>\n                    <Initials>A</Initials>\n                    <Identifier Source="ORCID">0000-0003-0191-8393</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Physics, Creighton University, Omaha, Nebraska.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>09</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>J Biophotonics</MedlineTA>\n            <NlmUniqueID>101318567</NlmUniqueID>\n            <ISSNLinking>1864-063X</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D019187">Cadmium Compounds</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D018036">Selenium Compounds</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D013440">Sulfides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D017967">Zinc Compounds</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>80168379AG</RegistryNumber>\n                <NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>A7F646JC5C</RegistryNumber>\n                <NameOfSubstance UI="C058667">cadmium selenide</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>KPS085631O</RegistryNumber>\n                <NameOfSubstance UI="C031238">zinc sulfide</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>ZS7284E0ZP</RegistryNumber>\n                <NameOfSubstance UI="D003630">Daunorubicin</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D019187" MajorTopicYN="N">Cadmium Compounds</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003630" MajorTopicYN="N">Daunorubicin</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004317" MajorTopicYN="N">Doxorubicin</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045663" MajorTopicYN="N">Quantum Dots</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018036" MajorTopicYN="N">Selenium Compounds</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013050" MajorTopicYN="N">Spectrometry, Fluorescence</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013440" MajorTopicYN="N">Sulfides</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017967" MajorTopicYN="N">Zinc Compounds</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">cancer</Keyword>\n            <Keyword MajorTopicYN="Y">chemotherapy</Keyword>\n            <Keyword MajorTopicYN="Y">fluorescence</Keyword>\n            <Keyword MajorTopicYN="Y">quantum dot</Keyword>\n            <Keyword MajorTopicYN="Y">radiotherapy</Keyword>\n            <Keyword MajorTopicYN="Y">reactive oxygen species</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>05</Month>\n                <Day>10</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>5</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30315626</ArticleId>\n            <ArticleId IdType="doi">10.1002/jbio.201800172</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'